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Abstract 
The mutational process is nonrandom. Distinct mutations in a given genomic 
segment can be the result of the same mutational event, rather than being the 
successive accumulation of mutations through generations, these are known as 
concurrent mutations. Two mechanisms are able to explain the origin of multiple 
mutations: the independent generation and successive accumulation of Single 
Nucleotide Substitution (SNS) and the occurrence of different mutations in a concurrent 
manner, concurrent Multiple Nucleotide Substitution (MNS). 
This thesis focuses on the identification of concurrent MNS from polymorphic 
variation in five human genes (BRCA1, LDLR, LRRK2, PSEN1, RET). Our analyses 
resulted in a total of 43 clusters with representative examples of distinct concurrent 
MNS (Tandem Base Mutations, Complex MNS and Noncontiguous MNS). Patterns of 
double, triple and more than three mutations were detected and analyzed. Other 
studies were performed such as what concerns the population specificity and the 
existence of a preference in the type of nucleotide substitution.The major outcome was 
the observation of a significant difference in the transition/transversion rate (RTs/Tv) 
between TBS and Noncontiguous MNS, which is independent of distance between 
mutations. 
In the Forensic Genetics field the estimation of the mutation rate is of critical 
importance. Thus, the simultaneous birth of mutations may impose some bias in 
current estimations. To date, concurrent mutations were only detected in the mutational 
spectra of human disease-causing genes. Our work, demonstrate the occurrence of 
concurrent mutations in the human polymorphic variation, which is of irrefutable 
relevance in upcoming estimations of the human mutation rate. 
 
 
 
Key-words: concurrent Multiple Nucleotide Substitutions, mutation rate, Tandem Base 
Mutation, Complex MNS, and Noncontiguous MNS. 
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Resumo 
O processo mutacional não é aleatório. Mutações múltiplas numa determinada 
região genómica podem ter sido geradas no mesmo evento mutacional, ao invés de 
terem resultado da acumulação sucessiva de mutações ao longo do tempo, sendo 
estas designadas por mutações concurrent. Existem dois mecanismos que são 
capazes de explicar a origem das mutações concurrent: a origem independente e 
acumulação sucessiva de Single Nucleotide Substitution (SNS) e a ocorrência de 
mutações múltiplas em simultâneo, concurrent Multiple Nucleotide Substitution (MNS). 
A atenção foi focada na identificação de concurrent MNS presentes em cinco 
genes humanos (BRCA1, LDLR, LRRK2, PSEN1, RET). A análise resultou num total 
de 43 clusters constituídos por diferentes concurrent MNS (Tandem Base Mutations, 
MNS complexos e MNS não contíguos). Foram detetados padrões em diferentes tipos 
de MNS: MNS duplos, triplos e MNS com mais de três mutações. Outras análises 
foram efetuadas, tais como a especificidade populacional das mutações em estudo e a 
verificação da existência da preferência no tipo de substituição nucleotídica. O 
principal resultado decorrente desta tese foi a observação de diferenças significativas 
na taxa de transição/transversão (RTs/Tv) entre Tandem Base Substitution e MNS não 
contíguos, o que se mostrou ser independente da distância entre as mutações.  
Na Genética Forense a correta estimação da taxa de mutação é de grande 
importância. O facto de existirem mutações que ocorrem em simultâneo faz com que 
existam desvios relativamente às taxas de mutação atualmente existentes. Até à data, 
mutações concurrent foram apenas detetadas em estudos centrados em mutações 
diretamente relacionadas com doenças. O presente trabalho demonstra a existência 
de mutações concurrent em polimorfismos humanos, o que é de relevância irrefutável 
em futuras estimativas da taxa de mutação do genome humano.. 
 
 
Palavras-chave: concurrent Multiple Nucleotide Substitutions, taxa de mutação, 
Tandem Base Mutation, MNS complexos e MNS não contíguos. 
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Introduction 
The concept of mutation: a very brief history 
In the 1900’s, the evolutionary biologist Hugo de Vries used, for the first time, 
the word mutation to indicate the sudden appearance of phenotypic variation (reviewed 
in [1]). His finding was based in the work with Oenothera lamarckiana. At the time, De 
Vries observed that when a plant was self-pollinated, some offspring were different 
from the progenitors. When F1 was self-pollinated, some plants were still distinct from 
the parents. The plants that passed the mutation to the progeny as an inheritable 
characteristic were considered a new species. To De Vries new species were not 
formed by continuous variation as Darwin has defended, but by the sudden 
appearance of variation. 
 In 1904 De Vries stated, “Natural selection may explain the survival of the 
fittest, but it cannot explain the arrival of the fittest” [2]. To De Vries and his 
contemporaneous colleagues the causes of mutation were not known, but in an 
attempt to explain it, he suggested the existence of “pangenes” which, when mutated, 
could immediately create a new species [3].  
Nowadays the concept of mutation is different: a mutation is not the observed 
phenotypic difference between parents and offspring, it is a change in the DNA 
sequence. This change can result from distinct mechanisms and may or may not led to 
phenotypic differences between individuals carrying distinct alleles.  
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Types of mutations on the DNA sequence 
In theory, a mutation can occur with similar probabilities in exonic, intronic or 
even regulatory regions. When a nucleotide is changed in the DNA sequence we are 
dealing with a Point Mutation. These type of mutations can be further divided into 
transitions (when the replacement involves a purine-to-purine or a pyrimidine-to-
pyrimidine change), and transversions (substitution of a purine to a pyrimidine or vice 
versa). When these mutations occur within exonic regions, they may alter the amino 
acid resulting in an incorrect protein sequence and these are known as missense 
mutations. The impact of the missense mutations is strongly dependent on the target 
protein where it occurs, that is, its degree of essentiality, the location on the protein, 
and on the physical and chemical similarity between the newly arisen amino acid and 
the original one.  
Substitutions that replace an amino acid with another with similar properties are 
conservative substitutions. It is expected that conservative replacements lead to less 
dramatic changes on protein function than non-conservative changes. Whenever the 
mutation introduces a premature STOP codon, the resulting protein is expectedly 
shorter (truncated protein) and, often, non-functional. Whenever these mutations 
involve genes involved in critical biological processes, serious implications are 
expected at the phenotypic level, and consequently in health [4].  
There are mutations that result from insertions (IN) and/or deletions (DEL) of 
one or few bases, they are called INDELS. As expected, the reading frame is altered 
and an altered protein is produced. This kind of mutation may provoke diseases, an 
example is the genetic disorder: cystic fibrosis [5]. This disorder is mostly caused by an 
INDEL in CFTR gene, which eliminates a single amino acid.  
  Duplication is a type of mutation characterized by a piece of DNA that is copied 
and is present in the genome more than one time. The duplication may occur at the 
entire gene or in just a part of it. Duplications of oncogenes are related with a number 
of cancers, for example, a high prevalence of cases with the oncogene KRAS 
duplicated was found in patients with colorectal cancer [6]. 
Another type of mutations can occur at repetitive stretches of DNA. Mutations 
that cause repeat expansions are, for instance, causative of the Machado-Joseph 
Disease (MJD’s), an late-onset autosomal dominant neurodegenerative disorder [7]. 
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The exon 10 of the ATXN3 gene, responsible for encode ataxin-3 in various tissues, 
has an unstable CAG repeat that when expanded may cause MJD.  
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The human mutation rate  
Mutation is the ultimate source of variation and, hence, is responsible for 
evolution and genetic diseases. The estimation of the rate of de novo mutations and 
their properties is an important subject in genetics, having implications in the 
understanding of the evolutionary process and the molecular basis of human diseases. 
The first attempts to estimate the human mutation rate were based on the 
observation of certain phenotypes or on the direct comparison of homologous 
sequences among closely related species [8-13]. J. B. S. Haldane was a pioneer in this 
field [10, 13]. He assumed the importance of accounting the rate at which a new 
mutation appears and the selective force to eliminate mutations that confers a 
reduction in fitness to estimate the human mutation rate. In the 1930s and 1940s, 
Haldane used the frequency of hemophiliac men to calculate the frequency of the 
disease-causing allele. A novel mutation causative of hemophilia was estimated to 
occur at a rate of approximately 10-5 per generation [10, 13]. 
  Another approach used the direct counts of affected offspring with a dominant 
disease or a recessive X-linked disease born from healthy parents [11]. Vogel and 
Motulsky summarized a list of diseases that fit these patterns of inheritance and the 
respective mutation rate was estimated as to vary from 10-6 to 10-4 per generation [14]. 
In passing, it should be mentioned that a critical failure of the methods that focus on the 
observation of phenotypes to calculate a mutation rate is the obvious underestimation 
of the true mutation rate of the gene since some mutations may have only slightly effect 
on phenotypes which may not be of clinical attention or even having no effect at all 
(neutral mutations).   
There are indirect methodologies to estimate the mutation rate based in the 
assumption that the mutation rate can be estimated through the rate of fixation of 
neutral mutations in a species [12]. Therefore, stretches of noncoding DNA (which is 
assumed to evolve neutrally) of two closely related species, such as chimpanzee and 
humans, are compared. Since the generation time and divergence from the last 
common ancestor of the two species are known, the mutation rate can be estimated.  
Using this approach,  the human mutation rate was estimated to be 10-8 per generation 
[9, 15].  
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In 2003, A. Kondrashov and collaborators estimated the mutation rate at 20 loci 
associated with Mendelian diseases [8]. The estimated mutation rate, taking into 
account all types of mutations, resulted similar to previous studies: 10-8, per generation. 
The work of A. Kondrashov included also an important dimension to the 
preceding estimates: the analyses of mutation rate by different types of mutation. The 
mutation rate of INDELS, for example, has been reported as 10-9 per site per 
generation, which corresponds to a lower value than the obtained for single nucleotide 
substitutions (SNP). It was also demonstrated that mutational hotspots such as the 
CpG dinucleotides have high mutation rates compared to non-CpG dinucleotides, an 
issue that is going to be explored in more detail below.  
With the next-generation sequencing and the possibility of study more genomic 
information at once emerged genome-wide studies that have more accuracy, are more 
direct and have more comprehensive tactics (reviewed in [16]). Whole-genome 
estimates based on pedigrees resulted in a human mutation rate of roughly 10-8 per 
base pair per generation.  
The human mutation rate may vary with innumerous factors. In this regard, 
Kong and collaborators demonstrated the influence of the father’s age in the rate of de 
novo mutations, where they found that the mutation rate was directed related with the 
father’s age at the time of conception [17]. On other hand, F.D. Conrad and 
collaborators observed that in one family the paternal germline was responsible for the 
most part of the mutation, but in another family it was the maternal germline. This 
demonstrate variation of the mutation rate between human pedigrees [18].  
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Source of Mutation 
For the purpose of this thesis some factors related with the heterogeneity of the 
mutational process will be explored in more detail. These are: (a) the DNA 
polymerases, (b) Non-B DNA conformations and (c) CpG dinucleotides.  
(a) DNA polymerases  
DNA polymerases are involved in all processes involved in DNA synthesis. 
Mutations in DNA polymerases or changes in their expression have a critical role in 
mutagenesis [19]. The humans have more than a dozen of different DNA polymerases, 
which only five of them are well understood and well stated as essential (Pol α, Pol β, 
Pol γ, Pol ε and Pol δ) (reviewed in [19]). The key function of these five polymerases is 
summarized in Table 1.  
Tab.1- Main function of the classical DNA polymerases. 
Type Function Reference 
Pol α Initiation of DNA replication [20] 
Pol β Base-excision repair [21] 
Pol γ Replication in mitochondrial DNA [22] 
Pol ε Synthesis of the leading strand of nuclear DNA [23] 
Pol δ Lagging strand synthesis and exonuclease activity [24] 
 
The aforementioned DNA polymerases are interrupted when DNA is damaged, 
but in order to bypass the innumerous mutations that happen in a cell there are DNA 
polymerases that are capable of get through precedent lesions: Translesion synthesis 
(TLS) DNA polymerases (reviewed in [25]). There are irrefutable differences between 
the classical DNA polymerases and TLS DNA polymerases: the first have higher 
replication taxes, higher processivity and higher fidelity (reviewed in [25, 26]).  
When DNA is damaged the replication process is blocked and, in order to 
continue, the switch of the DNA polymerase by a TLS polymerase is required. The non-
occurrence of this switch implies the cell dead. The switch implies the recruitment of 
the Proliferating Cell Nuclear Antigen (PCNA), a protein that binds DNA polymerase 
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and prevents the dissociation with the template DNA. The ubiquitination of PCNA 
allows interactions between the PCNA and TLS DNA polymerases [27, 28].  
(b) Non-B DNA Structure 
Since 1953, the DNA molecule is known to have a right-handed double helical 
structure with Watson–Crick base pairing, B-DNA conformation. However, some DNA 
regions enriched in repetitive sequences can adopt other forms known as non-B DNA 
conformations. There are about ten types of non-B DNA conformations, namely 
cruciform/harpin, triplex, slipped, tetraplex and left-handed Z-form (Table 2). By their 
nature, some sequences are more likely to form non-B DNA conformations but they are 
mainly formed when certain conditions result in negative supercoiling, encourage the 
separation of the DNA and histones and/or the separation of the two strands in 
processes such as the replication and transcription [29].  
The cruciform and hairpin conformations require an inverted sequence repeat of 
at least seven nucleotides. When both DNA strands are involved, the conformation is 
known as a cruciform, whereas when just one strand is involved it creates a hairpin 
[30]. The inverted repeats are complementary and pair with each other forming a 
structure with a hairpin and a loop arm. The energy needed for the formation of the 
aforementioned structures is believed to be provided by the negative supercoiling [31].  
Several homopurine:homopyrimidine sequences with mirror symmetry have the 
potential to form triplex DNA, this structure is characterized by the wind of a third strand 
with the usual duplexes [32].  
Slipped strand DNA conformations are formed when complementary strands 
with simple repeats are misaligned, forming a slipped structure with hairpins or lopped-
out bases. This kind of structures were only described in short repeats, but they may 
arise in every repeat [33].  
Sequences enriched in guanines are able to form a special conformation: a 
tetraplex [34]. In a tetraplex structure four guanines are bonded and form a square co-
planar of guanines. 
When an alternating purine-pyrimidine sequence occurs, the double helix of the 
DNA can wind to the left in a zig-zag configuration, forming a non-B DNA named Z-
DNA [35].  
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Tab.2- Summary of the sequence requirements by the most common non-canonical DNA structures. 
Name Conformation Sequence 
Requirements 
Example 
Cruciforme/Hairpin  
 
Inverted repeats  
 
Triplex 
 
Mirror repeat symmetries 
in 
polypurine/polypirimidine 
regions 
 
Slipped strand 
DNA 
 
Misalignment of simple 
repeats 
 
Tetraplex 
 
Sequence rich in 
Guanine 
 
 
Z-DNA 
 
Sequence with 
alternating pyrimidine 
and purine  
 
It has been shown that non-B DNA conformations have influence in some 
important biological processes such as chromatin architecture, gene expression 
regulation, DNA replication, DNA damage and repair and genetic instability [29, 36-38].  
Various studies demonstrate the influence of the occurrence of non-B DNA on 
promoting the genetic instability, increasing the number of mutations as large deletions 
or even single nucleotide substitution [38]. It has been showed this secondary 
structures being related with the increase of genetic anomalies such as deletions, 
rearrangements and chromosomal translocations (reviewed in [29]). ,A previous study 
analyzed the impact of introducing a sequence capable of form non-B DNA in a 
transgenic mice and the results showed that approximately 7% of the transgenic mice 
were carriers of large deletions and chromosomal translocation [39]. Some literature 
reported the association between the formations of non-B DNA structures at 
breakpoints of rearrangements and inherited diseases as, for instances, mental 
retardation, idiopathic pancreatitis and ornithine transcarbamylase deficiency [40-42].  
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The occurrence of genetic instability by the formation of non-canonical DNA 
structures can result from two mechanisms: replication-independent mechanism of 
non-B DNA-induced genetic instability and replication-dependent mechanism of non-B 
DNA-induced genetic instability.  
Some intrinsic characteristics of the replication process facilitate the emergence 
of non-B DNA conformation and genetic instability. The replication process itself may 
promote the transition for secondary structures by separating the two strands of DNA 
and providing the energy necessary to the occurrence of negative supercoiling [29]. An 
well, the replication process can impact the mutagenesis of the pre-existing non-B DNA 
structure. During replication the non-B DNA is likely to influence the fidelity of DNA 
polymerases and inducing replication fork stalling which prolongs the time where exists 
single strand DNA and prompt genetic instability [43, 44]. If the replication fork stalling 
is longer than the supported by the organism it may cause the cut off of both the 
strands of DNA (Double Strand Breaks-DSB) [29]. It was also observed that simple 
repeats occurring at non-B DNA conformations can promote the DNA polymerase 
slippage which results in the expansion or contraction of the number of repeats [45].  
Apart from the replication process, other biological processes can enable the 
formation of non-B DNA such are the transcription, damaged DNA and the mechanism 
of DNA repair itself. When DNA is damaged it may alters the DNA conformations, 
recruit proteins that interact with DNA or modify the chromatin proteins which can 
facilitate the formation of this structures [29]. The transition of a B to a non-B 
conformation can be stimulated by repairing mechanisms [29]. For example, the repair 
of an DBS in a short inverted repeat lead to an hairpin structure at the extremity of the 
break [46]. During transcription the two DNA strands are separated and the process 
generates negative supercoiling inducing the formation of non-B DNA [29]. Studies in 
the promoter region of the c-MYC gene revealed that the transcription is responsible for 
the formation of a non-B secondary structure [47].  
Replication-independent mechanisms like the aforementioned are able to result 
in genetic instability in non-B DNA structures [29]. Occasionally the non-canonic DNA 
structure can be confused with damaged DNA due to the chromatin distortions and 
repair mechanisms are activated which may lead to the cleavage of the DNA near the 
region of non-B DNA [29]. Non-B DNA conformations also my alters the exposure of 
the DNA to damaging agents or/and affect the accessibility of repair proteins [29]. 
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(c) CpG dinucleotide 
The CpG dinucleotide is a mutational hotspot. The first evidence of the 
hypermutability of the CpG dinucleotide was provided by Youssoufian et al. [48]. During 
the attempt to understand the molecular basis of hemophilia they observed the 
existence of recurrent mutations in the F7 gene, resulting from a CG→TG transition. 
This observation suggested the possibility that CpG dinucleotides could be a 
mutational hotspot. The validation arose from the study of Cooper and Youssoufian 
[49] in a number of disease-causing mutations, confirming the hypermutability of the 
CpG dinucleotide and the capacity to cause human genetic disease.  
In the human genome, unmethylated cytosine suffers spontaneous deamination 
to uracil. Because uracil is not a DNA base it is removed by the uracil-DNA glycosylase 
with high fidelity and the mutation is frequently repaired. However, when methylated 
cytosine deaminate to thymidine the repair machinery is less efficient because both are 
DNA bases (reviewed in [38]). It is important to mention that CpG transitions can occur 
due to mechanisms other than the more common spontaneous deamination of the 
5mC [50]. The methylation of CpGs is pointed to be influenced by non-B DNA 
conformations. A previous study demonstrated that the non-canonical DNA structures 
quadruplex had significantly low methylation of CpGs, revealing a inverse correlation 
between the number of CpGs in a sequence and the probability to form non-B 
structures [51]. 
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Mutational Clusters 
To estimate the mutation rate, the mutation process is assumed to be random 
and mutations to arise in an independent fashion. However, the existence of more 
mutants with multiple mutations than expected by chance alone showed that  this is not 
always the case: “although mutations are poorly predictable, they have been observed 
to be nonrandom” [52]. 
Most of the work in this field has been done using the Big Blue transgenic mice 
as a model [53, 54]. Assuming that the mutation were independent it was expected a 
frequency of doubles of 5,3x10-10, but, the observed frequency was much larger: 
3,5x10-7 [53]. In a similar work, Colgin and his collaborators while studying the HPRT 
gene noticed that mutations in a human epithetical cell line had four of their 12 
mutations separated by only six bases, this mutations were more closely spaced than 
the predicted by a random distribution [55].  
When multiple mutations occurs in a particular space region of the genome 
(Closely Spaced Multiple Mutations, CSMM) they are defined as mutational clusters 
[56, 57]. A mutational cluster can be explain by two mechanisms: (a) the successive 
accumulation of independent single nucleotide substitution (SNS) during evolution, or, 
(b) by a unique mutational event that originates different mutations in the same cell 
cycle, conducting to Concurrent Multiple Nucleotide Substitution (MNS) [56] (Figure 1). 
 
Fig.1- Birth of multiple mutations. a) This example shows three independent mutational events that creates a mutation 
cluster, so this cluster mutation does not arise in the same cell cycle. b) Multiple mutations occurring at the same 
mutational event. 
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Clustered mutations are not confined to small DNA fragments. In fact, the 
mutations may be within few bases or even have several kilobases separating them, 
giving rise to a mutation shower [52, 58]. A previous study add a limit of 30 Kb as the 
maximum distance of mutations in a shower [58] (Figure 2). 
 
 
Fig.2- Visualization of a mutation shower where colored circles represent each mutation of a cluster.  
 
Concurrent MNS are able to create compensatory mutations, where mutations 
that separately where deleterious together are advantage or neutral, and 
simultaneously generate pathogenic mutations. Like Zhu and his collaborators stated: 
“concurrent MNS mutations represent two sides of the same coin” [59]. Related 
evidence showed that the majority of the compensatory mutations is caused by 
mutational showers [52, 60].  
There are three types of MNS that differ in the distance between different 
mutations: (a) Tandem Base Substitution (TBS), (b) noncontiguous MNS and (c) 
complex MNS (Figure 3) [59].  
 
TBS 
 
Noncontiguous MNS 
 
Complex MNS 
 
Fig.3- Classification of MNS into three types: Tandem Base Substitution, Noncontigous MSN and Complex MNS. 
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The origin of concurrent MNS results mainly from two mechanisms: gene 
conversion and transient hipermutability [57].  
Gene conversion involves the transference of a portion of DNA from a donor 
sequence to an acceptor sequence with a minimum of 90% of homology [61] and it is a 
molecular mechanism used to repair two-ended DSBs, stabilizing chromosomal 
mispairing [62]. Gene conversion events tend to occur in regions enriched in CpG and 
regions that form stable hairpin structures [63].  
Transient hypermutability results from processes that implies the newly 
synthesis of DNA and the misincorporation of bases during DNA replication and repair: 
(a) problems in the replicative DNA polymerase and proteins implicated in the 
replication fidelity, (b) the disruption of the balance of the nucleotide pool or (c) the 
recruitment of an error-prone DNA polymerase [58, 61, 64, 65]. Cases of transient 
hypermutability were describe in somatic and germline cells [56]. The proportion of 
CpG is used a crude indicator to discriminate between MNS generated by transient 
hypermutability or just by the gradual accumulation of mutation in a mutagenic region, 
so the lower the CpG content the higher is the likelihood that the MNS have occurred 
by transient hypermutability  [56] [57]. An association exists between the enrichment in 
transversions and concurrent MNS formed via transient hypermutability. Previous 
evidence has shown that the transitions/transversions ratio (Ts/Tv) is lower in 
concurrent MNS than in SNS [59]. 
As shown in a previous section non-canonical DNA conformations have a great 
impact in biological mechanism including the replication process and the repair itself. 
Because these mechanisms are required to have a high fidelity to avoid mutation, 
when they are compromised by non-B DNA tend to cause instability which may 
promote the mutagenesis of the affected region. Repetitive segments with high 
mutability rates are expected to be more prone to generate concurrent MNS [38, 56]. 
DNA polymerases can bypass mutations and are able to replicate damaged 
DNA at low speed, low processivity and low fidelity through the switch of a classic DNA 
polymerase to a TLS DNA polymerases [19, 25, 26, 66]. There are studies that point 
out the role of TLS DNA polymerase in generating concurrent MNS [56, 67-69]. Chen 
and collaborators emphases the importance of this error-prone DNA polymerases in 
generating TBS and hypothesized that the major part of the double and triple TBS arise 
from errors introduced by TLS polymerases [67]. Most of the triples resulting from 
incorporation of incorrect bases during bypass of DNA lesions by the TLS polymerase. 
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The mechanism upon which TLS polymerase originates TBS is different for TBS with 
equal or less than three bases and those of more than three bases. In the first case the 
contiguous mutations are caused by the bypass of endogenous DNA lesions 
(incorporation of incorrect bases against the damage bases) and the second one by 
serial replication slippage (SRS).  
TBS are originated mostly by endogenous mechanisms and not by DNA lesions 
introduced by the exposure to exogenous agents like the UV radiation  [67]. 
Concurrently generated quadruplet to octuplet TBS are generally related with some 
signatures: the perfect or almost perfect reverse complements (in situ inversion) or the 
perfect or almost perfect matches near upstream sequences (neighboring sequence 
duplication) [67]. The same study showed the existence of signatures of the combined 
action of SRS and TLS polymerase in the birth of quadruplet to octuplet TBS. Most of 
them have microhomologies near the region with the MNS, consistent with the 
recruitment of the TLS polymerase during the SRS. In accordance,  the action of the 
TLS polymerase in generating complex MNS was recently documented [70].  
The mutation rate estimations are based on the assumption that mutations arise 
independently and randomly, which is now clear not to be the case. Thus, the non-
independence of mutations has a major role in the estimation of the human mutation 
rate because the presence of concurrent MNS mutations not considered in the 
estimation causes the overestimation of the human mutation rate. Now, it is important 
to recognize the specificity of the DNA regions and the occurrence of simultaneous 
mutations to account in futures mutation rate, in order to achieve a more accurate 
estimation of the mutation rate. Some work is this field has been done, for example, the 
mutational rate of double and triple TBS was estimated to be 0,2-1,2x10-10 and 0,8-
4,8x10-12 per base per generation, respectively. The mutation rate of double TBS was 
estimated to be 0,2-1% of the single-base substitution [67].  
Cancer genetics is complex and may involve multiple mutations where the most 
likely scenario is the simultaneous appearance of them, although only a few examples 
are available in related literature. An example is provided by Chen et al [71] showed 
the oncogene EGFR and the tumor suppressor TP53, genes related with lung cancer, 
had some doubles and multiples mutations with a pattern that suggest the 
simultaneous occurrence of the observed mutations during the same mutational event.  
Concurrent mutations are not exclusive in cancer related genes, they can occur 
in the entire genome. An example is found in mammalian mitochondrial OXPHOS 
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proteins, more specifically in the COI protein [72]. In the COI protein the Leu195-
Leu196 is the wild-type in humans and his very conserved among mammals. The 
deleterious Leu196Ile mutation is associated with an epileptic phenotype in humans but 
in Fat Dormouse (Myoxus glis) is the wild-type allele and was predicted to be tolerated 
due to the compensatory effect of a neighboring residue (Ile195). The simultaneous 
occurrence of a compensatory mutation allowed the fixation of Ile196 in the rodent 
lineage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                                     FCUP 
                                                                           Identification and analyzes of concurrent multiple nucleotide substitutions 26 
 
Aims 
This work was based on the analyses of SNPs in five genes related with a disease 
phenotype. The primary effort was to understand better the occurrence and the 
characteristics of concurrent mutations, a topic which was not extensively studied 
previously. The main goals were: 
 Evaluation the non-random distribution of the mutations by statistic methods 
 Identification of concurrent mutations  
 Investigate the possible mechanisms of formation of concurrent mutations 
 Identifying patterns in the different concurrent MNS 
 Establish general rules related to sequence specificities that may result in 
concurrent MNS. 
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Material and Methods 
Data mining  
Genotypic data was retrieved from phased 3 of the integrated variant call set of 
1000 Genomes Browser based on Ensembl v76 GRCh37 which contains genotypes 
from 2504 individuals across 26 human populations [73]. Here, we focused on five 
genes related with common diseases: the low density lipoprotein receptor (LDLR, 
chr19:11200038-11244492) that regulates the level of cholesterol in the blood [74], the 
tumor suppressor gene breast cancer 1 (BRCA1, chr17:41196312-41277500) [75-78], 
the presenilin 1 (PSEN1, chr14:73603126-73690399) which is associated with an 
early-onset form of Alzheimer disease [79-83], the ret proto-oncogene (RET, 
10:43572475-43625799), a transmembrane receptor tyrosine kinase involved in a large 
number of diseases [84], and the leucine-rich repeat kinase 2 (LRRK2, 
chr12:40590546-40763087) that encodes the Dardarin protein which has been 
associated with a late-onset form of Parkinson disease [85-88]. Further explanation 
about the genes addressed here are present in the Appendix I. 
  For each of the five genomic regions that encompass each of the five genes, 
the corresponding VCF file was retrieved and only single nucleotide polymorphisms 
were maintained for further analyses, that is, no INDELS were considered in this study. 
This strategy resulted in a total of 11419 SNPs distributed as follows: 1416 in LDLR, 
1957 in BRCA1, 2095 in PSEN1, 1569 in RET and 4382 in LRRK2.  
Data analyses 
Each SNP dataset was initially analyzed using a sliding window of 100 
nucleotides and steps of 30 nucleotides in order to assess the genomic regions that 
contain more polymorphisms than it would be expected by chance. The neutral 
expectation is that the mutational process occurs randomly, therefore, the expected 
distribution follows a Poisson’s distribution where the expected value of the number of 
mutations per site equals the average value. The comparison between the average and 
the expected value were performed with a Chi-square test using α = 0.05.  
The average value of the number of mutations per 100 bases was proximally 
2.8. We used this value to search each gene-specific SNP dataset in order to select the 
intervals where the number of mutations differs of two mutations from the immediately 
flanking interval (See Supplementary File I). This approach resulted in a total of 726 
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Clusters (RET: 112, PSEN1: 114, LRRK2: 269, LDLR: 94, BRCA1: 137), which were 
numerated for each gene in CL1, CL2 and pursuing this logic. 
The frequency of each variation was obtained from the data of 1000 Genomes 
Project and analyzed using python scripts (Python v.2.7.6.0, www.python.org/). Our 
interest was particularly the concurrent MSN, so it was established some criteria to 
improve the chance of finding the MNS generated simultaneously: in the previous 
clusters SNPs with an overall frequency of less than 10% (accepting a difference of 
10% to account possible errors) were chosen to ensure that mutations are recent 
events. After the filtering process, manual inspection of the clusters was performed to 
verify if the SNPs appear in the same individuals in order to increase the possibility of 
the haplotype that defines each cluster being generated by concurrent mutations 
(Supplementary File II). 
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Results and discussion 
According to the neutral expectation, if mutations accumulate randomly and 
independently across the genome, it is expected their distribution to follow a Poisson 
distribution.  We started to use all polymorphic sites to evaluate the distribution of 
polymorphic sites obtained from the 1000 Genomes Project for each of the five genes 
here studied, and obtained for an α = 0.05, all five genes showed a significant p value 
(LDLR p = 2.21171x10-26; PSEN1 p = 1.86026x10-12; BRCA1 p = 3.13311x10-07; RET p 
= 0.000337; LRRK2 p = 4.2233x10-08).This result was in accordance with a non-
random distribution of mutations across these genes.  
We next tried to detect mutations that appear to be linked on the same 
haplotype but not observed alone in a distinct haplotype, which could indicate their birth 
by the same mutational event. Polymorphism data extracted from the 1000 Genomes 
Project for the five genes here studied (BRCA1, LDLR, LRRK2, PSEN1, RET) were 
used to define the clusters (haplotypic backgrounds defined by putative concurrent 
mutations). This approach resulted in a total of 43 clusters: 1 cluster for BRCA1, 13 
clusters for LDLR, 14 clusters for LRRK2, 7 clusters for PSEN1 and 8 clusters for RET. 
The 43 clusters comprises a total of 103 distinct mutations. Among all these mutations, 
15.5% are localized at CpGs sites.  
Concerning to the type two complex MNS (BRCA1-CL1 and RET-CL7) and 13 TBS 
(LDLR: CL1, CL4, CL11; LRRK2: CL1, CL2, CL6, CL12, CL13, CL15; PSEN1: CL5; 
RET: CL2, CL3, CL4, CL5) were detected. The remaining concurrent MNS found were 
noncontiguous MNS (BRCA1:CL1; RET: CL7) (Table 3). 
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Tab.3- Mutation clusters detected through the analysis of standing variation based on SNPs from the 1000 Genomes 
Project. The number of mutations per cluster is indicated as so their location in each gene.  The type of concurrent MNS 
was defined according to the distance between mutations.  
Gene Cluster Nº SNP's CpGs Intron or/and Type of concurrent MNS
Exon
BRCA1 1 3 0 Intron 19 Complex MNS
LDLR 1 2 0 Intron 1 TBS
2 2 2/2 Intron 2 Noncontigous MNS
3 2 0 Intron 2 Noncontigous MNS
4 4 0 Intron 3 TBS
5 2 1/2 Intron 3 Noncontigous MNS
6 2 0 Exon 4 Noncontigous MNS
7 2 0 Intron 5 and Exon 6 Noncontigous MNS
8 2 1/2 Intron 6 Noncontigous MNS
9 2 1/2 Intron 7 Noncontigous MNS
10 2 0 Intron 8 Noncontigous MNS
11 2 0 Intron 9 TBS
12 2 0 Intron 9 Noncontigous MNS
13 2 0 Intron 15 Noncontigous MNS
LRRK2 1 2 0 Intron 1 TBS
2 2 0 Intron 1 TBS
3 3 0 Intron 1 Noncontigous MNS
4 3 0 Intron 7 Noncontigous MNS
5 2 0 Intron 9 Noncontigous MNS
6 2 0 Intron 16 TBS
7 2 0 Intron 20 Noncontigous MNS
8 2 0 Intron 20 Noncontigous MNS
9 2 0 Intron 24 Noncontigous MNS
10 2 0 Intron 44 Noncontigous MNS
11 4 2/2 Intron 45 and 49 Noncontigous MNS
12 2 0 Intron 46 TBS
13 2 0 Intron 49 TBS
14 2 0 Exon 54 Noncontigous MNS
PSEN1 1 2 2/2 Intron 4 Noncontigous MNS
2 4 1/4 Intron 4 and Exon 9 Noncontigous MNS
3 4 1/4 Intron 7 and 15 Noncontigous MNS
4 2 1/2 Intron 7 Noncontigous MNS
5 2 0 Intron 13 TBS
6 3 0 Intron 14 Noncontigous MNS
7 6 3/6 Intron 15, 16 and 18 Noncontigous MNS
RET 1 2 1/2 Intron 1 Noncontigous MNS
2 2 0 Intron 1 TBS
3 2 0 Intron 1 TBS
4 2 0 Intron 1 TBS
5 2 0 Intron 1 TBS
6 2 0 Intron 3 Noncontigous MNS
7 3 0 Intron 16 Complex MNS
8 2 0 Exon 20 Noncontigous MNS  
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A previous study focused in concurrent double TBS indicates the GC 
dinucleotide as the most frequent mutated dinucleotide (28.2%)  and the GC>AA/TT as 
the most frequent TBS alteration [67], with a frequency of 7.92% and 9.56%, 
respectively.  Our research is not motivated by concurrent TBS in particular, but by 
concurrent MNS in general. Therefore, our dataset only presents 13 TBS concurrent 
MNS, wherein only one is not a double TBS (LDLR-CL4) (Table 4). As shown in Table 
4, two double TBS have the GC dinucleotide as the wild-type allele (16.7%), which is 
lower than the value obtained previously (28.2%) [67], although it is likely to result from 
the bias introduced by the number of double TBS of our study. The dinucleotide 
change GC>TT was observed in PSEN-CL5 (8.33%), which is consistent with the 
conclusions of a previous studies where the authors conclude that this replacement is 
frequently associated with GC dinucleotides [67].  
An interesting and previously unreported observation could be made by a close 
look into the Table 4: there are two most common mutant alleles: AT (n=4) and TT 
(n=3), together they account for 58% of all the concurrent double TBS. This may 
suggest some kind of preference or even a signature of the mechanism underlying the 
generation of concurrent double TBS.  
Tab.4- Distribution of the 13 concurrent TBS 
TBS Gene Cluster Replacement  
1 LDLR-CL1 TC>CA 
2 LDLR-CL4 TGCC>ACTG 
3 LDLR-CL11 TG>CA 
4 LRRK2-CL1 GC>AT 
5 LRRK2-CL2 TC>AT 
6 LRRK2-CL6 GA>TT 
7 LRRK2-CL12 CC>AT 
8 LRRK2-CL13 CA>AT 
9 PSEN-CL5 GC>TT 
10 RET-CL2 GA>TG 
11 RET-CL3 TG>GA 
12 RET-CL4 GG>TT 
13 RET-CL5 GA>TG 
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The mutation rate and the type of mutation is dependent of the sequence 
context [38]. A very interesting study about the relation of dependency between the 
mutation rate and the nucleotides flanking the mutated allele in Pseudomonas 
fluorescens ATCC948 was made by H. Long [89]. This paper demonstrated a higher 
mutation rate for T bases with a G at 3’ and particularly an increase of T mutated when 
it was flanked by a G at 5’ and 3’. In line with this, our data show that of the total of 
mutations that occur at a T bases 62.5% (n=10) have a G at the 3’ flanking base. 
As shown in Figure 4, the clusters of mutations were grouped as doubles, when 
two polymorphic positions are contiguous, triple, whenever three mutations contribute 
to define the cluster and >3, when more than 3 mutations define the cluster. To a better 
understanding of how mutations at clusters with three or more than three mutations are 
distributed along the sequence the distance between the mutations is also shown in 
this figure.  
Pairs of putative concurrent mutations (doubles) were observed in all genes 
with the exception of BRCA1 for which a single cluster with three mutations were 
defined. Double mutations were the most frequent category observed among the set of 
genes here studied and the distance between the mutations at each pair that define the 
cluster is highly variable. For instance, in the case of LDLR, 12 clusters of double 
mutations were defined according to the criteria mentioned in the methodology section. 
The distance between the mutations at those clusters is very heterogeneous with only 
two clusters showing contiguous mutations and the remaining with mutations spaced 
by longer distances. Similar patterns of the distribution of double mutations were also 
observed at the LRRK2, PSEN1 and RET genes.  
 Clusters of three mutations were observed at the BRCA1, LRRK2, PSEN1 and 
RET. In these cases, it was possible to establish three patterns for the co-occurrence 
of three mutations based on their distance on the sequence: (1) two contiguous 
mutations and a third at a very short distance (one or two nucleotides) as is the case 
observed at the BRCA1 and RET and (2) three mutations separated by one or few 
nucleotides. Clusters of triple mutations are rare events and only five of these clusters 
could be observed in total.  
Rare are also clusters defined by more than three mutations. We observed five 
haplotypes defined by more than three mutations, one at the LRRK2 and LDLR and 
three at the PSEN1 gene. The cluster at the LDLR is defined by a set of four 
contiguous mutations, a pattern that clearly differs from that observed at the LRRK2 
                                                                                                                                                                                     FCUP 
                                                                           Identification and analyzes of concurrent multiple nucleotide substitutions 33 
 
and PSEN1.Taken together, the four clusters with more than three mutations at the 
LRRK2 and PSEN1 revealed an interesting distribution: pairs of closely linked 
mutations are separated by larger distances. This pattern is in accordance with the 
observations made for clusters of double mutations where the distance between any 
two mutations is never higher than 150 (PSEN1 CL4).  
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Fig.4- Cluster distribution according to the distance (in nucleotides) between concurrent MNS. For clusters with 3 (triple) 
or more mutations we use the average value of the distance between all mutations was used to include the cluster into 
one of the classes.  
We next analysed the population distribution of concurrent. mutations. The most 
frequent clusters are distributed across all human populations covered by the 1000 
                                                                                                                                                                                     FCUP 
                                                                           Identification and analyzes of concurrent multiple nucleotide substitutions 35 
 
Genomes (AFR, AMR, EAS, EUR and SAS): LDLR-CL9, LRRK2-CL2, LRRK2-CL8, 
PSEN-CL3, RET-CL3 (Appendix II). For these five common clusters an intesting 
observation can be made: there is a low frequency of the concurrent MNS in the 
African population.  The CL9 from the gene LDLR shows two concurrent MNS. This is 
an example that demonstrates high general frequency concurrent MNS in humans, 
although showing to be rare in  Africa (Figure 5).  
In some of the less frequent clusters the opossite is verified, where the 
concurrent MNS only apperas in the African population (BRCA1-CL1, LDLR-CL1, 
LDLR-CL2, LDLR-CL5, LDLR-CL6, LDLR-CL8, LRRK2-CL1, LRRK2-CL4, RET-CL4, 
RET-CL6, RET-CL8) (Appendix II).  
TBS are the most well studied cases of concurrent MNS and the underlying 
mechanism known. Using data from the human pathologic variation (disease-
associated mutations), some studies claim that a key role of TLS polymerases as 
responsible for most of the TBS [67]. It is important to clarify that TBS distribution 
ahead from the pathologic mutational spectrum was acessed. In this study, we used 
the polymorphic variation present in the entire sequence of five genes to demostrate 
the occurrence and frequency of TBS across human populations (Figure 5).  
The complex MNS (mutations that have noncontigous and contigous mutations 
simultaneously) are the less explored type of concurrent MNS, perhaps because they 
are uncommon among pathologic data. In our study we report two examples of 
complex MNS: BRCA1-CLA and RET-CL7. The two complex MNS have a low 
frequency and are confined to the African and East Asian populations, respectively 
(Figure 5).  
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Fig.5- DNA sequences from LDLR-CL9, LRRK2-CL2 and RET-CL7 and their respective distribution in human 
populations. The LDLR-CL9 represents a double noncontiguous MNS, the LRRK2-CL2 exemplifies a double TBS and 
the RET-CL7 is an example of a triple complex MNS. 
Once established that co-occurring mutations are not random we ask next 
whether or not a signature of preferred types of nucleotide substitutions may exist. 
Figure 6 shows the frequency of replacements from a total of 103 mutations that define 
the 43 clusters here analyzed. About 53% of all the concurrent mutations are 
transitions (A→G, T→C, C→T and G→A). There is evident the existence of two more 
common alterations: C→T and G→A (33% of all the concurrent MNS). The C→T 
transition is about 64% of the mutations that happen in the nucleotide C and the G→A 
accounts for 50% of all the mutations in the G nucleotide. Half of the C→T transitions 
and about 40% of the G→A transitions are located at the mutational hotspot of CpG 
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dinucleotides representing the deamination of cytosine to thymine and guanine to 
adenine in the other strand [38].  
 
 
Fig.6- Counting of the type of base change. In the bottom there is the wild-type mutation and above the alternative base. 
Although the data from genome-wide de novo SNS mutations is large 
(N=4933), our dataset for concurrent MNS is a small sample size (N=103; Table 3).  
In genome-wide studies of de novo SNS mutations, the RTs/Tv was estimated as 
to be 2.1 (3344/1589). The number of transitions in concurrent MNS was still higher 
than the transversions. However, the RTs/Tv was significantly lower to concurrent MNS 
(1.10) when compared to SNS (2.10), (p = 0.0009) (Table 5). Our data provides an 
example that reinforce the study made by Zhu et al. [59], where they concluded a 
decreased RTs/Tv in concurrent MNS. 
To evaluate the influence of the type of concurrent MNS in the 
transition/transversion ratio we used the number of transitions and transversions in 
TBS mutations (N= 28, Table 3) and Noncontigous mutations (N=69, Table 3). 
Complex MNS were not included because of the small sample size (N=2, Table 3). In 
TBS mutations more transversions (N=16) than transitions (N=12) were observed 
leading to a RTs/Tv <1 (0.75), whereas Noncontigous mutations reveal an enrichment in 
transitions to transversions (RTs/Tv=1.76). The differences between the RTs/Tv of TBS and 
noncontiguous MNS showed to be significant (p = 0.0486) (Table 5). 
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Recently, Zhu and collaborators [59] demonstrated  that the higher RTs/Tv values 
are related with a higher distance between concurrent mutations. Our dataset 
embraces most of the concurrent MNS in a closely spaced region (≤100 nucleotides, 
N=79) which is in concordance with the decrease of concurrent MNS with the increase 
of their distance [56]. 
For concurrent MNS with a maximum distance of 100 nucleotides the RTs/Tv 
value is 1.03 (40/39), which indicates a similar content of transitions and transversions. 
For concurrent MNS with compound mutations separated by more than 100 
nucleotides the RTs/Tv value (1.4) shows an increment in transitions over transversions 
(14/10). The Fisher’s exact test shows no significant differences between the two 
categories (p = 0.3352) (Table 5).  
Given the aforementioned results we can corroborate the results of Zhou et al. 
[56] when they affirm a decreased RTs/Tv in concurrent MNS over SNS. However, we 
are able to conclude by our dataset that according to the type of concurrent MNS there 
are an increase of transition in the case of the noncontiguous MNS and an increase of 
transversions in TBS. The same does not apply to the distance of the component 
mutations, where it was not shown a significant difference of RTs/Tv values in the two 
different classes. The genome is characterized by a bias in transition mutations [17], 
but we denote the increment in transversion in the TBS witch is consistent with the 
signature of TLS polymerase [67]. As stated before, some studies demonstrate that 
mutagenesis caused by TLS polymerases is common in TBS mutations [67].  
 
Tab.5- Comparison between the RTs/Tv values for 133 Concurrent MNS and 4933 Genome-wide de novo SNS mutations, 
28 TBS and 69 Noncontigous MNS and 79 concurrent MNS with  a separation ≤100 nucleotides and 24 concurrent 
MNS separated by more than 100 nucleotides. The RTs/Tv for genome-wide de novo SNS mutations was provided by 
[59]. A Fisher’s exact test was used to obtain the level of significance between different classes.  
 
N RTs/Tv P value 
Genome-wide de novo SNS mutations 4933 2.1 (3344/1589) 
0.0009 
Concurrent MNS (All) 103 1.1 (54/49) 
    TBS 28 0.75 (12/16) 
0.0486 
Noncontigous MNS 69 1.76 (44/25) 
    ≤100 nucleotides 79 1.03 (40/39) 
0.3352 
>100 nucleotides 24 1.4 (14/10) 
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Conclusions 
The main aim of this work was to detect concurrent MNS in five genes (used as 
case studies). We were able not only to demonstrate that concurrent mutations are 
present among the polymorphism spectra of the human genome but also that not all 
the mutations are independent and some arise simultaneously from the same 
mutational event. In passing, it shall be noted that this is the first study that identifies 
concurrent mutations from non-pathologic data. We also demonstrated that the 
mechanism of origin of different SNS is also different. In this regard, TBS mutations 
show a clear signature of being originated by TLS polymerases.  
In forensic genetics the mutation process itself can lead into misinterpretation of 
the results. Therefore, a good estimation of a mutation rate is very useful to forensic 
genetics. The thematic of concurrent MNS is of major importance for forensic 
applications because the occurrence of simultaneous mutations prevents an accurate 
estimation of the human mutation rate. The mutation rate is an important reference for 
forensic genetics. Nowadays it is more robust to calculate a regional mutational rate 
instead of a general mutation rate that is assumed to be equal to every region, every 
nucleotide and every circumstance, although it starts to be obvious that this is a 
simplification of the mutational process. 
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Future perspectives  
During the study of concurrent MNS I was aware of the existence of non-B DNA 
conformations that may confer some genetic instability to some genetic regions. This 
genetic instability sometimes conduce to very mutable regions or sites, potentiating 
sometimes the emerging of simultaneous and dependent multiple mutations. As an 
attempt to visualize the influence of such biological mechanism it was performed the 
prediction of the non-B DNA conformation for our sequences. The results of the stable 
and probable to exist non-B DNA conformations are in Appendix III and an example is 
provided by Figure 7, where it is visible that the three complex MNS are inside the loop 
of the non-B DNA conformation, which may explain their birth. In my point of view it 
would be extremely interesting to do further studies in the specific implications of this 
non-canonical DNA structures in the promotion of phenomenon that lead to the origin 
of concurrent MNS. 
As well, it is important to expand the pilot study here presented to the entire 
genome in order to establish general rules that may be important to have in 
consideration in further estimations of the human mutation rate. 
 
Fig.7- Example of a prediction of the non-B DNA structure for BRCA1 gene CL1 with a concurrent MNS in the 
loop. The software UNAFold 3.8 [90] was used to predict the non-B structure of each sequence of the previous selected 
clusters, being the sequence ten bases after the first mutation of the cluster and ten bases before the last one. The 
program uses principals of energy minimization, some algorithms and stochastic sampling to predict the folding of 
sequence of DNA. The number of folding were reduced for two and then it was used the default parameters. In the 
cases where there was more than one predicted structure it was chosen the one with the lowest free energy (ΔG) 
because a lower value of ΔG implies a more stable structure.  
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Appendix 
Supplementary Files (provided in electronic format): 
Supplementary File I: Selection of clusters by analyze of flanking regions with a difference of 2 mutations. 
Supplementary File II: Compilation of the concurrent mutations with the respective allelic frequency and identification 
of individuals carrying the mutations. 
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Appendix I: Detailed description of the studied genes 
BRCA1 
BRCA1 (Breast cancer 1, early onset) is a tumor suppressor gene and some 
variants potentiate the risk of having breast, ovarian and prostatic cancers and they are 
linked to a hereditability predisposition to this types of cancers [75-78] . BRCA1 has an 
important role in the DNA repair during cellular processes such as cell divisions [91-
93]. BRCA1 is also involved in another cellular process: the transcriptional regulation. 
The interference of its transcriptional activity can lead to tumorigenesis [94]. 
RET 1 
RET (RET proto-oncogene) is a oncogene that encodes a transmembrane 
receptor tyrosine kinase which is responsible for signaling within cells and it is involved 
in various cancers and diseases [84]. This signaling process is extremely important to 
the development of some types of nerve cells, such as the enteric neurons [95]. 
Studies revealed RET as a gene with influence in the normal development of the 
kidney [95, 96]. 
LDLR 
The expression of low density lipoprotein receptor is carried out by the LDLR 
(low density lipoprotein receptor) gene. The receptor binds two low density lipoprotein 
that are responsible for transport the cholesterol in the blood and they regulate the 
extent of cholesterol in the blood [74]. There are variants in the LDLR gene causing a 
disease named familial hypercholesterolemia [97-100]. Mutations in the LDLR gene 
can reduce the number of receptors in cells and/or they may reduce the receptor’s 
capability to remove low-density lipoproteins form the blood resulting in an excess of 
cholesterol and a higher risk of cardiac problems [74]. 
PSEN1 
PSEN1 (Presenilin 1) encodes a protein called Presenilin which is involved in 
proteolytic processes by making part of the complex γ-secretase localized in the 
membrane, this protein important to cleave proteins and transmit signals from outside 
of the cell to inside [101]. The best known function of Presenilin is its implication in the 
metabolism of a protein with impact in the formation of nerve cells [102, 103]. 
Innumerous variants in PSEN1 are known to be responsible for early-onset Alzheimer 
disease [79-83]. Hidradenitis suppurativa, a skin disease, can be caused by one 
deletion in this gene (725delC) [104]. 
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LRRK2 
LRRK2 (Leucine-rich repeat kinase 2) express the Dardarin protein. The 
previous mentioned protein has various functions such as interact with another 
proteins, in order to transmit signals or to help cytoskeleton reorganization [105].  
Dardarin has another known function: kinase activity, critical for numerous cell activity 
[106]. Several mutations in this gene are responsible for Parkinson disease later-onset 
or increase the risk of get the disease [85-88]. 
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Appendix II: Sequence of the genes BRCA1, LDLR, LRRK2, PSEN1 and RET with the annotation of the concurrent MNS and the respective population distribution. 
BRCA1 
 
CL1 
41254760 GAGATGTAGACTACAGTGAGCTATGATCACTCCACTGCACTTCAGCGTGGGCGGCAAAGC 41254701 
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LDLR 
 
CL1 
11200818 CGCCCGGCCGGGACCCTCTCTTCTAACTCGGAGCTGGGTGTGGGGACCTCCAGTCCTAAA 11200877 
 
 
 
 
 
 
 
CL2 
11204838 TGAGATGGAGTTTTGCTCTTGCTGCCCAGGCTGGAGTGCAATGGCGCGATCTCGGCTCAC 11204897 
11204898 CGCAACCTCCACCTCCTGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGA 11204957 
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CL3 
11204898 CGCAACCTCCACCTCCTGGTTCAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGA 11204957 
 
 
 
 
 
 
 
 
CL4 
11212218 CACTGCAAGCTGTGCCTCCTGGGTTCATGCCATTCTCCTGCCTCAGCCTCCCGAGTAGCT 11212277 
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CL5 
11212818 GCGTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCAAGATCGTGCCACTGTACTCCAGCCT 11212877 
 
 
 
 
 
 
 
CL6 
11214558 CTGATAGAAAATTGCAAGTTAGCTCACTGCAACCTCGGCATTATAAGTACTGCACAAAGC 11214617 
11214618 CCTCTTCAGCGCACAGCACAAGCACCATTCTATAAAATCTCCAGCAAGCGGCCAGGTGCA 11214677 
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CL7 
11216958 ACGATTATGGCTCACTGCGGCCTTGATCTCCTTGGCTCAAGCGATCCTCTCACTTCAGCC 11217017 
11217018 TCTCAAGCAGTTGGAACCACAGGCTGTACCACCAAGCCTGGCCAATTTTTTTGTACAGAC 11217077 
 
 
 
 
CL8 
11217918 ACAGGCACAAACCACCGTGCCCGACGCGTTTTCTTAATGAATCCATTTGCATGCGTTCTT 11217977 
11217978 ATGTGAATAAACTATTATATGAATGAGTGCCAAGCAAACTGAGGCTCAGACACACCTGAC 11218037 
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CL9 
11218218 AGTTTGTGGGGAGCCAGGAAAGGGACTGAGACATGAGTGCTGTAGGGTTTTGGGAACTCC 11218277 
11218278 ACTCTGCCCACCCTGTGCAAAGGGCTCCTTTTTTCATTTTGAGACAGTCTCGCACGGTCG 11218337 
11218338 CCCAGGCTGGAGCGCAATGGCGCGATCTCGGCTCACTGCAACCTCTGCCTCCCAGGTTCA 11218397 
 
 
 
 
CL10 
11222058 ATTACATCTCCCGAGAGGCTGGGCTGTCTCCTGGCTGCCTTCGAAGGTGTGGGTTTTGGC 11222117 
11222118 CTGGGCCCCATCGCTCCGTCTCTAGCCATTGGGGAAGAGCCTCCCCACCAAGCCTCTTTC 11222177 
11222178 TCTCTCTTCCAGATATCGATGAGTGTCAGGATCCCGACACCTGCAGCCAGCTCTGCGTGA 11222237 
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CL11 
11222958 TGTATTTTTAGTAGAGACGGGGTTTCACTGTGTTAGCCAGGATGGTCTCGATCTCCTGAC 11223017 
 
 
 
 
 
 
 
 
CL12 
11223798 CCTGTTCCCGTTGGGAGGTCTTTTCCACCCTCTTTTTCTGGGTGCCTCCTCTGGCTCAGC 11223857 
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CL13 
11232918 CGCCTGCCACTACGCCCGGCTACTTTTTTGTATATTTAGTAGAGATGGAGTTTCACTGTG 11232977 
11232978 TTAGCCAGGATGGTCTCGATCTCCTGACTTTGTGATCCGCCCGCCTCGGCCTCCCAAAGT 11233037 
11233038 GCTGGGATTACAGGCGTGAGCCACCATGCCAGGCTTTTTTTTTTTTTTTTTTTTTTGAGA 11233097 
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LRRK2 
 
 
CL1 
40604826 ACCCACCTGTGACCTGGAAGCCCCCTCCCTGCTCCAAGTTGCTTAGGGAAAAAAAATAAA 40604885 
 
 
 
 
 
 
 
 
 
CL2 
40605126 CTCCTCAAGGCCCAGGGACTATCATGGAAAAGGTGGGTGTGTGAGAATGTAAGAGTCAAT 40605185 
 
 
 
                                                                                                                                                                                     FCUP 
                                                                           Identification and analyzes of concurrent multiple nucleotide substitutions 53 
 
 
 
 
 
 
CL3 
40606626 TGTGAGTGTTCTTAACTTACAATAACACAGTTATTTGTATAAGTGCAGTGAAAATCTGTT 40606685 
 
 
 
 
 
 
 
 
 
CL4 
40634106 TAGCTTGTTTTCTCATTATAACATTCTTAGGAAGGGCTGCTTCACAGAAATATATTTTTT 40634165 
40634166 ATTTAAGGAGATTACACTTGATGTATCTCACACAACTATAATGAATATTGTAATTTTTGA 40634225 
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CL5 
40641246 TATATAAAAATATGTATATAAATATATACACATTGTATATAAATGTGTATATATATTTAC 40641305 
 
 
 
 
 
 
 
 
 
 
CL6 
40667166 AGATGATAAATGAAATGATGTCCAAGCTGAGCAATTAAAGTGTGAAGTAGAAGGACACAG 40667225 
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CL7 
40675266 GATGATCAGAGAAAGATTGCAGGGATAAGAAATTATGCTTTTGATAATCTTTAGTTATAT 40675325 
40675326 TCTTAATTTTCTTCATTATTATTTAAATGTAAAAATAAATATCTGTGAGCAGTAGTATTT 40675385 
 
 
 
 
 
 
 
CL8 
40677546 TTGCCTTATTTTATTTTGTTTCATTCCAAATTGGAGATGTAGAGAAAAATCACATGAAGT 40677605 
40677606 TTGATTTGCCAGTCTCCTAAAAGGAAGAAAAATGTAGATTTTTAATATACTTAATTTTTT 40677665 
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CL9 
40688166 TGAAAGACCTGTTCTAACCTATTCTCCAATTTTGATTATAGCTGAGTACTAAAAATATGA 40688225 
40688226 GGGTTGTTTTGTGTTAATTCTAGATCTTAAGATGGGTGAAATGAATGACTGTAGTTGAAT 40688285 
 
 
 
 
 
 
 
 
CL10 
40723146 TGCTATGTGAGATGAGGAAAATTAACGCTATTCTTTCTCCTTTTCCCATCACCTTCTCAA 40723205 
40723206 GTTCTTTAATTTATTCTATTATTTTTATGTAGTGAAAGTTTATAACATTTATATTCTGGT 40723265 
 
 
 
0
0
0
0
0 
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CL11 
40730406 CTTCTTTCTCTTCTGAAATGCTATGAATATGCCTTTTAGGTAGTATCCAGAAATGTTCCT 40730465 
40730466 TCCTGAAAGGGTCCAGAAACTACTGAAAACTGTACAGATTATGAAATGAAACAGGGTGCA 40730525 
40730526 ……………………………………………………………………………………………………………………………………………………………… 40746785 
40746786 CAGACGGGGTGGCAGCCGGGCAGAGGGGCTCCTCACTTCCCAGAAGGGGCGGCCGGGCAG 40746845 
40746846 AGGCGCCCCCCACCTCCCAGACGGGGCGGCGGCCGGGCGGGGGCTGCCCCCCACCTCCCG 40746905 
40746906 GATGGGGTGGCTGCCCAGCGGAGACGCTCCTCACTTCCCAGACGGGGCGGCTGCTGGGCG 4074696 
 
 
 
 
 
 
CL12 
40738746 GTGTAGTAGGGGTTATCATACTCAAATTCGATGTCTCCATCCTTCCAACTCTTCATGCTT 40738805 
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CL13 
40746306 CGCAGAGGGGGATTTGGCAGGGTCATAGGACAATAATGGAGGGAAGGTCAGCAGATAAAC 40746365 
 
 
 
 
 
 
 
 
 
CL14 
40762986 TTCATTGTTACTTTGTATTTGCAATTTTTTTTACCAAAGACAAATTAAAAAAATGAATAC 40763045 
40763046 CATATTTAAATGGAATAATAAAGGTTTTTTAAAAACTTTAAA                   40763087 
 
PSEN1 
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CL1 
73608706 CGGAGCTTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAGCCTGGGCGACAGAGGGAGA 73608765 
73608766 CTCCGTCTCAAAAAAAAAAAAAAGAAAAGAAACTACATCTCAATAATAATAATAATTTCA 73608825 
 
 
 
 
 
 
 
CL2 
73612006 CTATGGGTTTTTCCATAATGGAGTGTACTTTTATTATTTTATTATTTGTTTTTTTGAGAC 73612065 
73612066 AGGGTCTCACTCTGTCACTCAGGCTGGAGTGTAGTGATGCAGTCACTGCTCACTGCAGCT 73612125 
73612126 ……………………………………………………………………………………………………………………………………………………………… 73635165 
73635166 CTGATTGTCGGAAATACAAGCCACTGAGTGTTGGTGATACAAGTGGCTGAGCAGCGAGCA 73635225 
 
 
 
 
CL3 
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73620886 TAAACACAACTATGTATACCTGTGTGTATATATTGAAAAACGTTAGCATTTGGGGTGTCG 73620945 
73620944 ……………………………………………………………………………………………………………………………………………………………… 73671945 
73671946 AGGCTGAGGCGGGCGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCTAACACAGTGA 73672005 
73672006 AACCCCACCTCTACTAAAAAAAATACAAAAAATTAGCCAGGCATGGTGGCGGGCGCCTGT 73672065 
73672066 AGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGCGTGAACCCAGGAGACGGAGCTT 73672125 
 
 
 
 
 
 
CL4 
73622626 ATGTAGGTTCATCTGTTGTAACGGTTTACCACAGTGGTGCAGGATGTTGATAGAGGCTGT 73622685 
73622686 TGGAGGGGTTATGTGGGAACTCTGTGTACTTTCTGCTCAGTTTTGCTGTGGATCTAAGTT 73622745 
73622746 TGCATTTAAAAATATTTTATGGCTTGGTGGCTCATACTTGTAATCCTAGCACTTTGGAAG 73622805 
73622806 GCTGAGGCGGGTGGATCACTTGAGTTCAGGAGTTTGAGACCAGCCTGGGCAACATGGTGA 73622865 
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CL5 
73657966 CTACTCTTCTCTCACACTACTTTGCATAAATGGGATCATAAATGGGATCCTATATTTTTT 73658025 
 
 
 
 
 
 
 
 
CL6 
73663786 ACGCGCCACCACACCCAGCTAATTTTTTGTATTTTTTAGTAGAGACAGGGTTTCACCGTG 73663845 
73663846 TTAGCCAGGATGGTCTTGATCTCCTGACCTTGTGATCCGCCCACCTCGGCCTCCCAAAGT 73663905 
 
 
 
 
CL7 
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73670746 GCCCAGGCTGGAGTGCAATGGCACGATCTCGGCTCACCACAGCCTCCGCCTCCTGGATTC 73670805 
73670806 AAGCAATTCTCCTGCCTCAGCCTCCCGAGTCGCCGGGATTATAGACATGCACCACCACAC 73670865 
73670866 ……………………………………………………………………………………………………………………………………………………………… 73674885 
73674886 TTCTCTCCTTCTCGCCACCTGCAACGTGGCAAGTGGGGGGCACGTTTCAGCCCTGTTTGT 73674945 
73674946 CTTACGGTTCTTTCAATCCTGCCATTCAATGGGTCCCAAGTTCTTGTCCTGCATCCAGGA 73675005 
73675006 AGAATGAAGTACGTGGACAGCTGGAGGGAGAGCAAGATGAAAAGGTGCTTTATTGAGCAA 73675065 
73675066 ……………………………………………………………………………………………………………………………………………………………… 73679925 
73679926 CTCAGTTACCACAGTAATTAGGTTGCCTCTTCTACTTTCCTCTTTTCTCACAGGCACCAG 73679985 
73679986 GAGCCAGAGGAAATAACATAATAGTTGTTGACCAGAGCAGCAGCATAATTCTTTCATGAC 73680045 
73680046 TGCCTTTTCTAATTTGACGATTCCCTCTCCTGAGAGGGCTCTTTGTGTCCTCCTCCTCTT 73680105 
73680106 CGTCTCCAACTTTTAAAAAAAAAAAAGTGAAACTATCAAGTATTGCTCCTGCTAACTTCA 73680165 
 
 
 
 
 
 
RET 
 
1 
1 
1 
1 
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CL1 
43583575 TGATGGTGGTGGAGGCAGTTGTGGTGGTGATGGTGCTGGTGGAGGCAACGGTGATGGTGG 43583634 
43583635 TGGTGATGGTGAAGACGGTGGTGGGAATGGTGGTGGTGGAGGCAATGGTGGTGGTGATGG 43583694 
 
 
 
 
 
 
 
 
CL2 
43583635 TGGTGATGGTGAAGACGGTGGTGGGAATGGTGGTGGTGGAGGCAATGGTGGTGGTGATGG 43583694 
 
 
 
 
 
 
 
1 
1 
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CL3 
43583635 TGGTGATGGTGAAGACGGTGGTGGGAATGGTGGTGGTGGAGGCAATGGTGGTGGTGATGG 43583694 
 
 
 
 
 
 
 
 
CL4 
43590235 GCTTGTTAGAGCCCTATTGGCAGTGTGAGAATGTGTGAGCATATGGGAGAACAAGTGTAT 43590294 
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CL5 
43590895 AGGCCCGCCTGGGCATGAGAACATGCACACCTGGACGGAGTGTGTGGATTGACAAGGTGT 43590954 
 
 
 
 
 
 
 
 
CL6 
43599295 AGGCATGGTTCTGCCTGGGAGGCTTGTGGAGTTGCCCCCGCCTCCTTGGGGTGGGTTGTG 43599354 
43599355 GGGTCTTCAGCGGTGACCTTCCGCCTTCAGCATGCCCCCTTTTCTGGATTATTTCTGGAG 43599414 
 
 
 
 
1 
1 
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CL7 
43618495 CGCCCAGTGACCTCTGGCTGCCCTCTGGTGTGCTCCGTGGTGTGCACATGTATGCTTTTT 43618554 
 
 
 
 
 
 
 
 
CL8 
43625275 ACGTAACCTGGCTCTAATTTGGGCTGTTTTTCAGATACACTGTGATAAGTTCTTTTACAA 43625334 
 
 
Subtitle: 
 Intron 
 Exon 
 SNP 
1 
1 1 
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Appendix III: Predicted structures  
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